Blockade of VIP during neonatal development induces neuronal damage and increases VIP and VIP receptors in brain.
Section on Molecular and Developmental Pharmacology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
J M
JM
Hill
R F
RF
Mervis
J
J
Politi
S K
SK
McCune
I
I
Gozes
M
M
Fridkin
D E
DE
Brenneman
D000375:Aging / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn; D001345:Autoradiography; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D015870:Gene Expression / Q000187:drug effects; D017403:In Situ Hybridization; D007457:Iodine Radioisotopes; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009928:Organ Specificity; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D018005:Receptors, Vasoactive Intestinal Peptide / Q000096:biosynthesis*; D012016:Reference Values; D014660:Vasoactive Intestinal Peptide / Q000037:antagonists & inhibitors* / Q000096:biosynthesis* / Q000494:pharmacology
D007457:Iodine Radioisotopes; D012333:RNA, Messenger; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide